UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: August 4, 2022
Accession Number:
Submission Type:
CIK: 0001716947
Company Name: Ensysce Biosciences, Inc.
File Number: 333-266338